BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23342005)

  • 1. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.
    Liu CM; Hsieh CL; He YC; Lo SJ; Liang JA; Hsieh TF; Josson S; Chung LW; Hung MC; Sung SY
    PLoS One; 2013; 8(1):e53795. PubMed ID: 23342005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
    Chang L; Gong F; Cui Y
    Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
    Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
    Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
    Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
    Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC
    Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.
    Chen W; Lu Q; Li S; Zhang X; Xue X
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33146718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer.
    Seo JH; Jeong ES; Choi YK
    BMC Cancer; 2014 Mar; 14():175. PubMed ID: 24618206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.
    Zhang X; Zhang D; Qu F; Hong Y; Cao J; Pan X; Li L; Huang Y; Huang H; Yin L; Chen L; Ren J; Wang Z; Xu D; Cui X
    Mol Cell Biochem; 2014 Nov; 396(1-2):1-8. PubMed ID: 25169742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.
    Chang AC; Lin LW; Chen YC; Chen PC; Liu SC; Tai HC; Wu HC; Sung SY; Lin TH; Tang CH
    Int J Biol Sci; 2023; 19(3):760-771. PubMed ID: 36778124
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
    Sung SY; Wu IH; Chuang PH; Petros JA; Wu HC; Zeng HJ; Huang WC; Chung LW; Hsieh CL
    Oncotarget; 2014 Oct; 5(20):9911-29. PubMed ID: 25294816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of SCIN inhibits human prostate cancer cell proliferation and induces G0/G1 phase arrest.
    Wang D; Sun SQ; Yu YH; Wu WZ; Yang SL; Tan JM
    Int J Oncol; 2014 Jan; 44(1):161-6. PubMed ID: 24212916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
    Najy AJ; Day KC; Day ML
    Cancer Res; 2008 Feb; 68(4):1092-9. PubMed ID: 18281484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells.
    Cui X; Xu D; Lv C; Qu F; He J; Chen M; Liu Y; Gao Y; Che J; Yao Y; Yu H
    BMB Rep; 2011 Aug; 44(8):547-52. PubMed ID: 21871180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
    Jiang N; Zhou LQ; Zhang XY
    Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.
    Hoefer J; Schäfer G; Klocker H; Erb HH; Mills IG; Hengst L; Puhr M; Culig Z
    Am J Pathol; 2012 May; 180(5):2097-107. PubMed ID: 22449952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9.
    Yang X; Cui Y; Yang F; Sun C; Gao X
    Mol Med Rep; 2017 Sep; 16(3):3565-3572. PubMed ID: 28713950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.